References
- BertrandNLerouxJ-CThe journey of a drug-carrier in the body: an anatomo-physiological perspectiveJ Control Release2012161215216322001607
- DindaSCPattnaikGNanobiotechnology-based drug delivery in brain targetingCurr Pharm Biotechnol201414151264127424910011
- MorosMMitchellSGGrazuVde la FuenteJMThe fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcomeCurr Med Chem201320222759277823627938
- BernackiJDobrowolskaANierwinskaKMaleckiAPhysiology and pharmacological role of the blood-brain barrierPharmacol Rep200860560062219066407
- AlyautdinRKhalinINafeezaMIHaronMHKuznetsovDNanoscale drug delivery systems and the blood–brain barrierInt J Nanomedicine2014979581124550672
- DominguezASuarez-MerinoBGoni-de-CerioFNanoparticles and blood–brain barrier: the key to central nervous system diseasesJ Nanosci Nanotechnol201414176677924730296
- XuGMahajanSRoyIYongKTTheranostic quantum dots for crossing blood–brain barrier and providing therapy of HIV-associated encephalopathyFront Pharmacol2013414024298256
- GabathulerRDevelopment of new peptide vectors for the transport of therapeutic across the blood–brain barrierTher Deliv20101457158622833968
- JonesATGateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptidesInt J Pharm20083541–2343818068916
- GaldieroSVitielloMFalangaACantisaniMIncoronatoNGaldieroMIntracellular delivery: exploiting viral membranotropic peptidesCurr Drug Metab20121319310422292812
- VoneschCUnserMA fast thresholded landweber algorithm for wavelet-regularized multidimensional deconvolutionIEEE Trans Image Process200817453954918390362
- GaldieroSVitielloMD’IsantoMThe identification and characterization of fusogenic domains in herpes virus glycoprotein B moleculesChembiochem20089575876718311743
- GaldieroSFalangaAVitielloMThe presence of a single N-terminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type 1 glycoprotein HJ Biol Chem201028522171231713620348105
- GaldieroSFalangaAVitielloMAnalysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein HJ Biol Chem200828344299933000918678872
- GaldieroSFalangaAMorelliGGaldieroMgH625: a milestone in understanding the many roles of membranotropic peptidesBiochim Biophys Acta201518481 Pt A162525305339
- FalangaAVitielloMTCantisaniMA peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dotsNanomedicine20117692593421664490
- SmaldoneGFalangaACapassoDgH625 is a viral derived peptide for effective delivery of intrinsically disordered proteinsInt J Nanomedicine201382555256523901273
- TaralloRAccardoAFalangaAClickable functionalization of liposomes with the gH625 peptide from herpes simplex virus type I for intracellular drug deliveryChemistry20111745126591266821956538
- GuarnieriDFalangaAMuscettiOShuttle-mediated nanoparticle delivery to the blood–brain barrierSmall20139685386223135878
- CarberryTPTaralloRFalangaADendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular deliveryChemistry20121843136781368522968943
- FalangaATaralloRGaldieroECantisaniMGaldieroMGaldieroSReview of a viral peptide nanosystem for intracellular deliveryInt J Nanomedicine201371071599
- RapaportDShaiYInteraction of fluorescently labeled pardaxin and its analogues with lipid bilayersJ Biol Chem19912663523769237751748653
- BaschongWSuetterlinRLaengRHControl of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM)J Histochem Cytochem200149121565157211724904
- ViegasMSMartinsTCSecoFdo CarmoAAn improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissuesEur J Histochem2007511596617548270
- JaskolskiFMulleCManzoniOJAn automated method to quantify and visualize colocalized fluorescent signalsJ Neurosci Methods20051461424915935219
- LanniAMorenoMLombardiAGogliaFCalorigenic effect of diiodothyronines in the ratJ Physiol1996494Pt 38318378865078
- LuCTZhaoYZWongHLCaiJPengLTianXQCurrent approaches to enhance CNS delivery of drugs across the brain barriersInt J Nanomedicine201492241225724872687
- PatelMMGoyalBRBhadadaSVBhattJSAminAFGetting into the brain: approaches to enhance brain drug deliveryCNS Drugs2009231355819062774
- DemeuleMRéginaAAnnabiBBertrandYBojanowskiMBéliveauRBrain endothelial cells as pharmacological targets in brain tumorsMol Neurobiol200430215718315475625
- PardridgeWMBlood–brain barrier deliveryDrug Discov Today2007121–2546117198973
- DoolittleNDMinerMEHallWASafety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumorsCancer200088363764710649259
- HallWDoolittleNDamanMOsmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomasJ Neurooncol200677327928416314949
- FawellSSeeryJDaikhYTat-mediated delivery of heterologous proteins into cellsProc Natl Acad Sci U S A19949126646688290579
- Schutze-RedelmeierMPGournierHGarcia-PonsFIntroduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivoJ Immunol199615726506558752913
- BorlonganCVEmerichDFFacilitation of drug entry into the CNS via transient permeation of blood–brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, CereportBrain Res Bull200360329730612754091